Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 4/20 | 0.52 |
| ▸ | LRRK2 | Q5S007 | 7/20 | 0.50 |
| ▸ | ALK | Q9UM73 | 4/20 | 0.42 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.40 |
| ▸ | INSR | P06213 | 2/20 | 0.40 |
| ▸ | IGF1R | P08069 | 1/20 | 0.40 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.40 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.40 |
| ▸ | CLK1 | P49759 | 1/20 | 0.40 |
| ▸ | CLK2 | P49760 | 1/20 | 0.40 |
| ▸ | CLK3 | P49761 | 1/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.40 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.40 |
| ▸ | TTK | P33981 | 3/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22985894 | 1.00 | DYRK1A (0.52) | DYRK1ALRRK2ALKPTK2INSR | |
| SCHEMBL22985886 | 0.92 | LRRK2 (0.54) | DYRK1ALRRK2ALKPTK2INSR | |
| SCHEMBL22985920 | 0.91 | LRRK2 (0.52) | DYRK1ALRRK2ALKPTK2INSR | |
| SCHEMBL22985862 | 0.87 | LRRK2 (0.65) | DYRK1ALRRK2ALKINSRIGF1R | |
| SCHEMBL22985891 | 0.87 | LRRK2 (0.53) | DYRK1ALRRK2ALKPTK2INSR | |
| SCHEMBL22985870 | 0.86 | DYRK1A (0.70) | DYRK1ALRRK2DYRK3CSNK1ECLK1 | |
| SCHEMBL18018941 | 0.86 | DYRK1A (0.70) | DYRK1ALRRK2DYRK3CSNK1ECLK1 | |
| SCHEMBL18018937 | 0.86 | DYRK1A (0.70) | DYRK1ALRRK2DYRK3CSNK1ECLK1 | |
| SCHEMBL22985863 | 0.82 | ALK (0.63) | DYRK1ALRRK2ALKPTK2INSR | |
| SCHEMBL22958103 | 0.81 | LRRK2 (0.67) | DYRK1ALRRK2DYRK3CSNK1ECLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778604-A1 | LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | Dana Farber Cancer Institute, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| EP-3778605-A2 | LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | Dana Farber Cancer Institute, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |